Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Sales | 12,997 | 11,544 | 17,691 | 8,749 | 9,355 |
| Cost of Goods | 1,822 | 1,980 | 873 | 978 | 983 |
| Gross Profit | 11,175 | 9,564 | 16,818 | 7,771 | 8,372 |
| Operating Expenses | 18,938 | 19,712 | 19,204 | 18,423 | 21,931 |
| Operating Income | -6,941 | -9,167 | -1,513 | -9,674 | -12,576 |
| Interest Expense | 150 | -9,762 | 276 | -1,450 | 170 |
| Other Income | -557 | -2,000 | -430 | -1,139 | -1,599 |
| Pre-tax Income | -7,648 | -1,405 | -2,219 | -9,363 | -14,346 |
| Net Income Continuous | -7,648 | -1,405 | -2,219 | -9,363 | -14,346 |
| Net Income | $-7,648 | $-1,405 | $-2,219 | $-9,363 | $-14,346 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.08 | -0.35 | -0.55 |
| EPS Basic Continuous Ops | -0.18 | -0.04 | -0.08 | -0.36 | -0.56 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.08 | -0.35 | -0.57 |
| EPS Diluted Continuous Ops | -0.17 | -0.04 | -0.08 | -0.34 | -0.55 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | -0.34 | -0.57 |
| EBITDA(a) | $-5,697 | $-6,818 | $842 | $-7,501 | $-10,703 |